1. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol.,2005
2. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Alfred Witjes;Eur. Urol.,2017
3. Erdafitinib in locally advanced or metastatic urothelial carcinoma;Loriot;N. Engl. J. Med.,2019
4. Treatment options for metastatic urothelial carcinoma after first-line chemotherapy;Tassinari;Cancer Manag Res,2022
5. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol.,2000